bd 1047 has been researched along with fluvoxamine in 3 studies
| Studies (bd 1047) | Trials (bd 1047) | Recent Studies (post-2010) (bd 1047) | Studies (fluvoxamine) | Trials (fluvoxamine) | Recent Studies (post-2010) (fluvoxamine) |
|---|---|---|---|---|---|
| 118 | 0 | 54 | 2,051 | 518 | 434 |
| Protein | Taxonomy | bd 1047 (IC50) | fluvoxamine (IC50) |
|---|---|---|---|
| D | Rattus norvegicus (Norway rat) | 0.54 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0038 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.54 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.1 | |
| Transporter | Rattus norvegicus (Norway rat) | 0.54 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egashira, N; Fujiwara, M; Harada, S; Iwasaki, K; Matsushita, M; Mishima, K; Nishimura, R; Okuno, R; Orito, K | 1 |
| Ago, Y; Hiramatsu, N; Matsuda, T; Takuma, K; Yano, K | 1 |
| Chen, X; Fo, Y; Guo, Y; Liu, X; Qu, C; Shi, S; Yang, B; Ye, T; Zhang, C | 1 |
3 other study(ies) available for bd 1047 and fluvoxamine
| Article | Year |
|---|---|
Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine.
Topics: Animals; Behavior, Animal; Brain; Butyrates; Disease Models, Animal; Dose-Response Relationship, Drug; Ethylenediamines; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Morpholines; Obsessive-Compulsive Disorder; Paroxetine; Phenazocine; Piperazines; Psychotropic Drugs; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor; Tropanes | 2007 |
Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both 5-HT reuptake inhibition and σ(1) receptor activation.
Topics: Adrenalectomy; Animals; Dopamine; Ethylenediamines; Fluvoxamine; Male; Mice; Mice, Inbred Strains; Norepinephrine; Orchiectomy; Phenazocine; Prefrontal Cortex; Receptors, Serotonin; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Serotonin; Sigma-1 Receptor; Synaptic Transmission | 2011 |
Chronic inhibition of the sigma-1 receptor exacerbates atrial fibrillation susceptibility in rats by promoting atrial remodeling.
Topics: Action Potentials; Animals; Atrial Fibrillation; Atrial Remodeling; Calcium Channels, L-Type; Connexins; Ethylenediamines; Fluvoxamine; Gap Junction alpha-5 Protein; Heart Atria; Heart Rate; Male; Nitric Oxide Synthase Type III; Oncogene Protein v-akt; Rats; Receptors, sigma; Sigma-1 Receptor | 2019 |